Paul Hastings advised Oakley Capital on the deal. Uria Menendez also advised Oakley Capital, while Simpson Thatcher and A&O represented Cegid. K&L Gates advised the Grupo...
Oakley Capital’s $6.8 Billion Merger With Cegid Group
OneWeb’s Proposed Combination With Eutelsat Communications
Herbert Smith Freehills has advised OneWeb on the deal, while Weil and PwC Société d’Avocats advised Eutelsat and its Board. Paul Hastings advised Hanwha Systems. OneWeb,...
Fast Pace’s Investment in First Care Clinics
Paul Hastings LLP advised Fast Pace on the deal. Fast Pace, a portfolio company of Revelstoke Capital Partners and a provider of outpatient healthcare services to...
Castik Capital’s Acquisition of Artus Beteiligungs GmbH
Dechert and White & Case advised Castik Capital on the deal. Heuking Kühn Lüer Wojtek advised Odewald KMU II. Paul Hastings advised Permira Credit. Castik Capital,...
Société Générale Capital Partenaires’ Minority Investment in Crouzet Group
Paul Hastings (Europe) LLP advised Société Générale Capital Partenaires on the deal. Gibson Dunn advised Tikehau ACE Capital and Bpifrance. Delaby & Dorison and Valoren advised...
Bosch Rexroth’s Acquisition of HydraForce
Paul Hastings LLP advised HydraForce, while Latham & Watkins LLP represented Bosch Rexroth on the deal. HydraForce, a leader in high performance hydraulic fluid power cartridge valves, custom...
IK Partners’ Financing for the Acquisition of Groupe Batisanté
Allen & Overy Paris and Paul Hastings (Europe) LLPhas advised the investment group IK Partners on the deal. The deal concerned the financing of the acquisition of...
SD Biosensor and SJL Partners’ $1.53 Billion Acquisition of Meridian Bioscience
Rothschild & Co is serving as exclusive financial advisor and Jones Day and Keating Muething & Klekamp PLL are serving as legal counsel to Meridian. Piper...
Hanwha Energy USA Holdings Corporation’s US$300 Million Green Bonds Offering
Paul Hastings LLP represented Hanwha Energy USA Holdings Corporation on the deal. Hanwha Energy USA Holdings Corporation announced its issuance of US$300 million 4.125% Senior Green...
Orchestra BioMed’s $110 Million Series D Financing
Paul Hastings LLP advised Orchestra BioMed on the deal. Orchestra BioMed, a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced the closing of a $110...
Orchestra BioMed’s Collaboration with Medtronic
Paul Hastings LLP advised Orchestra BioMed on the deal. Orchestra BioMed announced a strategic collaboration with Medtronic to develop Orchestra BioMed’s BackBeat Cardiac Neuromodulation Therapy™ (CNT™) as...
Orchestra BioMed’s Merger with Health Sciences Acquisitions Corporation 2
Paul Hastings LLP advised Orchestra BioMed on the deal. Loeb & Loeb LLP served as legal counsel for HSAC2. Latham & Watkins LLP represented the capital...